- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: AF-802, RG-7853,CH5424802 中文名稱:阿來替尼,艾樂替尼
Alectinib是一種有效的ALK抑制劑,在無細胞試驗中IC50為1.9 nM,對L1196M突變型敏感,對ALK比PF-02341066, NVP-TAE684和PHA-E429選擇性高。
Alectinib Chemical Structure
CAS: 1256580-46-7
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
NIH/3T3 | Antitumor assay | 50 mg/kg | 10 days | Antitumor activity against mouse NIH/3T3 cells expressing EML4-ALK L1196M mutant xenografted in nude mouse assessed as tumor stasis at 50 mg/kg, po qd administered for 10 days | 27131066 |
NIH/3T3 | Antitumor assay | 50 mg/kg | 10 days | Antitumor activity against mouse NIH/3T3 cells expressing EML4-ALK L1196M mutant xenografted in nude mouse assessed as partial tumor regression at 50 mg/kg, po qd administered for 10 days | 27131066 |
MKN-45 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
NCI-H1993 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
NCI-H2009 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
Calu-1 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
NCI-H23 | Growth inhibitory assay | ~10 μM | IC50=3600 nM | 21575866 | |
PC-1 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
Calu-3 | Growth inhibitory assay | ~10 μM | IC50=>10,000 nM | 21575866 | |
NCI-H2228 | Growth inhibitory assay | ~10 μM | IC50=53 nM | 21575866 | |
SK-N-FI | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
KELLY | Growth inhibitory assay | ~10 μM | IC50=62 nM | 21575866 | |
NB-1 | Growth inhibitory assay | ~10 μM | IC50=4.5 nM | 21575866 | |
HDLM-2 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
SR | Growth inhibitory assay | ~10 μM | IC50=6.9 nM | 21575866 | |
KARPAS-299 | Growth inhibitory assay | ~10 μM | IC50=3 nM | 21575866 | |
NCI-H2228 | Kinase assay | ~1 μM | prevents autophosphorylation of ALK | 21575866 | |
SNU-5 | Growth inhibitory assay | ~10 μM | IC50=1800 nM | 21575866 | |
KATO-III | Growth inhibitory assay | ~10 μM | IC50=7900 nM | 21575866 | |
SK-BR-3 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
BT-483 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
PC-3 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
22Rv1 | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
U-87 MG | Growth inhibitory assay | ~10 μM | IC50>10,000 nM | 21575866 | |
H3122 | Growth inhibitory assay | ~10 μM | IC50=33 nM | 25096400 | |
LC-2/ad | Apoptosis assay | ~1 μM | induces apoptosis | 25349307 | |
LC-2/ad | Function assay | ~1 μM | inhibits the MAPK signaling pathway | 25349307 | |
Ba/F3 | Function assay | ~1 μM | suppresses phosphorylation of ERK and increases the abundance of BIM | 25349307 | |
SNU-2535 | Growth inhibitory assay | ~10 μM | IC50=33.1 nM | 26849637 | |
SNU-2535 | Kinase assay | ~1 μM | inhibits the phosphorylation of ALK and its downstream molecules ERK1/2 and AKT | 26849637 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK C1156Y mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.002 μM. | 26568289 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK S1206Y mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.002 μM. | 26568289 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of wild type EML4-ALK (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.002 μM. | 26568289 | |
KARPAS299 | Antiproliferative assay | 96 hrs | Antiproliferative activity against human KARPAS299 cells after 96 hrs by cell counting assay, IC50 = 0.003 μM. | 22225917 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK F1174L mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.003 μM. | 26568289 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK G1269A mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.009 μM. | 26568289 | |
NCI-H3122 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human NCI-H3122 cells after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.009 μM. | 26568289 | |
KARPAS299 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human KARPAS299 cells after 72 hrs by SRB/CCK-8 assay, IC50 = 0.015 μM. | 27131066 | |
NCI-H3122 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human NCI-H3122 cells after 72 hrs by SRB/CCK-8 assay, IC50 = 0.0174 μM. | 27131066 | |
SUP-M2 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SUP-M2 cells after 72 hrs by SRB/CCK-8 assay, IC50 = 0.0179 μM. | 27131066 | |
NCI-H3122 | Function assay | 72 hrs | Inhibition of ALK expressed in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB/CCK-8 assay, IC50 = 0.019 μM. | 27131066 | |
NCI-H3122 | Antiproliferative assay | 72 hrs | Antiproliferative activity against ALK-dependent human NCI-H3122 cells after 72 hrs, IC50 = 0.019 μM. | 26476749 | |
SU-DHL1 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SU-DHL1 cells after 72 hrs by SRB/CCK-8 assay, IC50 = 0.0205 μM. | 27131066 | |
NIH/3T3 | Antiproliferative assay | 72 hrs | Antiproliferative activity against mouse NIH/3T3 cells expressing wild type EML4-ALK after 72 hrs by SRB/CCK-8 assay, IC50 = 0.0323 μM. | 27131066 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK 1151Tins mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.072 μM. | 26568289 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK L1196M mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.09 μM. | 26568289 | |
NIH/3T3 | Antiproliferative assay | 72 hrs | Antiproliferative activity against mouse NIH/3T3 cells expressing EML4-ALK L1196 mutant after 72 hrs by SRB/CCK-8 assay, IC50 = 0.132 μM. | 27131066 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK L1152R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.169 μM. | 26568289 | |
Ba/F3 | Function assay | 72 hrs | Inhibition of EML4-ALK G1202R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay, IC50 = 0.207 μM. | 26568289 | |
DFCI114 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human DFCI114 cells expressing EML4-ALK G1269A mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.207 μM. | 26568289 | |
CHLA20 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human CHLA20 cells expressing EML4-ALK R1275Q mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.43 μM. | 26568289 | |
Kelly | Antiproliferative assay | 72 hrs | Antiproliferative activity against human Kelly cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.434 μM. | 26568289 | |
DFCI76 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human DFCI76 cells expressing EML4-ALK L1152R mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.511 μM. | 26568289 | |
LAN5 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human LAN5 cells expressing EML4-ALK R1275Q mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.617 μM. | 26568289 | |
SMS-KCNR | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SMS-KCNR cells expressing EML4-ALK R1275Q mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.765 μM. | 26568289 | |
SK-N-SH | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SK-N-SH cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 0.872 μM. | 26568289 | |
SH-SY5Y | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SH-SY5Y cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 1.15 μM. | 26568289 | |
SK-N-BE(2) | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SK-N-BE(2) cells expressing wild type EML4-ALK after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 1.554 μM. | 26568289 | |
LAN1 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human LAN1 cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 2.004 μM. | 26568289 | |
SK-N-AS | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SK-N-AS cells expressing wild type EML4-ALK after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 2.139 μM. | 26568289 | |
SK-N-FI | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SK-N-FI cells expressing wild type EML4-ALK after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay, EC50 = 2.401 μM. | 26568289 | |
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Alectinib是一種有效的ALK抑制劑,在無細胞試驗中IC50為1.9 nM,對L1196M突變型敏感,對ALK比PF-02341066, NVP-TAE684和PHA-E429選擇性高。 | ||||||
---|---|---|---|---|---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | CH5424802作用于ALK 為ATP競爭性的,解離常數(shù)(KD)為2.4 nM。CH5424802對ALK 和L1196M 具有強大的抑制效果,Ki分別為0.83 和1.56 nM。 CH5424802 作用于表達EML4-ALK的NCI-H2228 NSCLC細胞,抑制ALK自磷酸化。 CH5424802 也抑制STAT3 和AKT,而不是 ERK1/2的磷酸化。CH5424802 完全抑制STAT3在Tyr705位點的磷酸化。CH5424802優(yōu)先有效作用于表達EML4-ALK的 NCI-H2228細胞,而不作用于融合ALK的陰性 NSCLC細胞系,包括單層培養(yǎng)的HCC827細胞(EGFR外顯子19缺失), A549細胞(KRAS突變), 或NCI-H522細胞(EGFR 野生型, KRAS 野生型, 和ALK野生型)。CH5424802作用于 NCI-H2228球體細胞,引起凋亡標記—caspase-3/7樣激活。CH5424802抑制含NPM-ALK融合蛋白的兩種淋巴瘤細胞, KARPAS-299和SR生長,為不影響不含ALK融合的 HDLM-2淋巴瘤細胞生長。[1] CH5424802 作用于KARPAS-299具有高度靶向選擇性和更強的抗增殖活性。CH5424802抑制KAPRAS-299,IC50為3 nM, 抑制KDR, IC50為1.4 μM。CH5424802代謝穩(wěn)定性很高。[2] | |||
---|---|---|---|---|
激酶實驗 | 體外激酶抑制檢測 | |||
在CH5424802存在時,通過時間分辨熒光共振能量轉移(TR-FRET)分析或熒光偏振(FP)法測量磷酸化各種底物肽的能力,而測評抑制各種激酶(除了MEK1和 Raf-1)的能力。在CH5424802存在時,通過定量分析重組ERK2 蛋白對底物的磷酸化而測評對MEK1的抑制活性。在 CH5424802存在時,通過測定激酶磷酸化MEK1的能力而測評對Raf-1的抑制活性。 | ||||
細胞實驗 | 細胞系 | NSCLC, A549 和 HCC827 細胞 | ||
濃度 | 0-1 μM | |||
孵育時間 | 5天 | |||
方法 | NSCLC, A549 和HCC827細胞接種在96孔板中過夜,與不同濃度CH5424802按指定時間溫育。球體細胞生長抑制實驗中,細胞接種在球板上,溫育過夜,然后在指定時間用化合物處理。通過發(fā)光細胞活性檢測存活細胞。使用Caspase-Glo 3/7 檢測試劑盒進行Caspase-3/7檢測。 | |||
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot |
pALK / ALK / pAKT / AKT / pERK / ERK / pS6 / S6
感谢您访问我们的网站,您可能还对以下资源感兴趣: 天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口 |